Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 10 (6), 440-444
- https://doi.org/10.3816/cbc.2010.n.057
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinomaBreast Cancer Research and Treatment, 2008
- Increased Dose Density Is Feasible: A Pilot Study of Adjuvant Epirubicin and Cyclophosphamide followed by Paclitaxel, at 10- or 11-Day Intervals with Filgrastim Support in Women with Breast CancerClinical Cancer Research, 2007
- State-of-the-Art Therapeutics: Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2005
- R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacyLeukemia & Lymphoma, 2005
- The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2003
- Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young AdultsJournal of Clinical Oncology, 2003
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancerEuropean Journal of Cancer, 1998
- INTRAVENOUS OR ORAL ADJUVANT CMF FOR NODE‐POSITIVE BREAST CANCERAnz Journal of Surgery, 1992
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerThe New England Journal of Medicine, 1981